Dermira (NASDAQ: DERM) reported Q2 EPS of ($0.16), $0.05 worse than the analyst estimate of ($0.11). Revenue for the quarter came in at $15.01 million versus the consensus estimate of $14.93 million.

For earnings history and earnings-related data on Dermira (DERM) click here.